Lipid-lowering therapy with pravastatin reduces coronary plaque volume: Role of high-density lipoprotein cholesterol containing apolipoprotein A-1

被引：0

作者：

Tani, S ^{[1
]}

Watanabe, I ^{[1
]}

Oguchi, S ^{[1
]}

Anazawa, T ^{[1
]}

Takahashi, H ^{[1
]}

Nomoto, K ^{[1
]}

Miya, N ^{[1
]}

Ishikawa, K ^{[1
]}

Matsumoto, M ^{[1
]}

Nosaka, T ^{[1
]}

Kobari, T ^{[1
]}

Miyazawa, T ^{[1
]}

Furukawa, K ^{[1
]}

Miyamoto, T ^{[1
]}

Nagao, K ^{[1
]}

Kanmatsuse, K ^{[1
]}

机构：

[1] Nihon Univ, Surugadai Hosp, Tokyo, Japan

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2003年 / 41卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：296A / 296A

页数：1

共 50 条

[1] REDUCTION OF HIGH-DENSITY LIPOPROTEIN CHOLESTEROL AND APOLIPOPROTEIN A-I CONCENTRATIONS BY A LIPID-LOWERING DIET
VESSBY, B
BOBERG, J
GUSTAFSSON, IB
KARLSTROM, B
LITHELL, H
OSTLUNDLINDQVIST, AM
ATHEROSCLEROSIS, 1980, 35 (01) : 21 - 27
[2] Paradoxical decrease in serum high-density lipoprotein cholesterol and lipid-lowering drugs
Crook, M. A.
ANNALS OF CLINICAL BIOCHEMISTRY, 2011, 48 : 3 - 4
[3] Relation between high-density lipoprotein efflux capacity and coronary plaque progression in type 2 diabetes patients with intensive lipid-lowering therapy
Imaizumi, S.
Iwata, A.
Takata, K.
Zhang, B.
Miura, S.
Saku, K.
EUROPEAN HEART JOURNAL, 2015, 36 : 812 - 812
[4] Low-density lipoprotein, non-high-density lipoprotein, and apolipoprotein B as targets of lipid-lowering therapy
Grundy, SM
CIRCULATION, 2002, 106 (20) : 2526 - 2529
[5] Low-density lipoprotein, non-high-density lipoprotein, and apolipoprotein B as targets of lipid-lowering therapy
Feeman, WE
CIRCULATION, 2003, 107 (20) : E199 - E199
[6] Pravastatin reduces major coronary events in patients with low levels of both high-density lipoprotein cholesterol and low-density lipoprotein cholesterol: Results from the LIPID study
Colquhoun, D
Marschner, I
Simes, J
Glasziou, P
Keech, A
White, H
Barter, P
Tonkin, A
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 262A - 262A
[7] Raising high-density lipoprotein cholesterol and lowering low-density lipoprotein cholesterol as adjunctive therapy to coronary artery revascularization
Bates, ER
AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (12A): : 28L - 34L
[8] High density lipoprotein, apolipoprotein A-1, and coronary artery disease
Rai Srivastava
Neelam Srivastava
Molecular and Cellular Biochemistry, 2000, 209 : 131 - 144
[9] Lower levels of high-density lipoprotein cholesterol are associated with increased cardiovascular events in patients with acute coronary syndrome receiving contemporary lipid-lowering therapy
Nakazawa, M.
Arashi, H.
Inagaki, Y.
Otsuki, H.
Yamaguchi, J.
Ogawa, H.
Hagiwara, N.
EUROPEAN HEART JOURNAL, 2020, 41 : 1639 - 1639
[10] Role of Lipid-Lowering Therapy in Low-Density Lipoprotein Cholesterol Goal Attainment: Focus on Patients With Acute Coronary Syndrome
Wang, Qinqin
Liang, Chun
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2020, 76 (06) : 658 - 670

← 1 2 3 4 5 →